The nation of Zimbabwe has rejected a major US healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' insistence on confidential biological samples.
This rejection became public following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesman later explained that the US was demanding access to genetic material for scientific study and commercial purposes but was unwilling to share the benefits from future treatments.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to find a deal agreeable to all parties so the nation's critical HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a similar health funding agreement after concerns were filed about the safety of citizens' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.
Based on statements, 16 African countries have so far agreed to similar health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that might be developed from that provided information," Mangwana explained.
"In essence, our country would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our population should a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks already established through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This framework is designed to ensure that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how subsequent collaboration could be arranged in a way that honours the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that talks must proceed given that much of the nation's Aids initiatives depended on foreign aid.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it added.
This impasse underscores the complex debate between receiving crucial foreign assistance and protecting a country's data in an increasingly interconnected world.